Uma H. Athale - Concepedia

Author

Uma H. Athale

McMaster University ORCID

Also Known As

U Athale, U H Athale, U. Athale, U. H. Athale, U.H. Athale, Uma Athale, Uma H Athale, Uma H. Athale, Uma Harish Athale

196

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

McMaster University McMaster Children's Hospital Centre Hospitalier Universitaire Sainte-Justine Hamilton Health Sciences Dana-Farber Cancer Institute

About

Uma H. Athale is an author at McMaster University specializing in medicine, pediatrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	1.1K
2	Health Sciences	5	5	128
3	Public Health	4	4	188
4	Clinical Nutrition	2	2	75
5	Arts	1	1	14

Uma H. Athale

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial Steven E. Lipshultz, Rebecca E. Scully, Stuart R. Lipsitz, The Lancet Oncology Drug SafetyHematological MalignancyOncologyDoxorubicin-treated ChildrenPediatric Hematology	2010	442
Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes Steven E. Lipshultz, Tracie L. Miller, Rebecca E. Scully, Journal of Clinical Oncology	2012	319
Postinduction Dexamethasone and Individualized Dosing of <i>Escherichia Coli</i> L-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01 Lynda M. Vrooman, Kristen E. Stevenson, Jeffrey G. Supko, Journal of Clinical Oncology	2013	308
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial Andrew E. Place, Kristen E. Stevenson, Lynda M. Vrooman, The Lancet Oncology MedicineMicrobiologyOpen-label Phase 3Dfci 05-001	2015	234
Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience Uma H. Athale, Bassem I. Razzouk, Susana C. Raimondi, Blood	2001	222
Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes Steven E. Lipshultz, Tracie L. Miller, Stuart R. Lipsitz, PEDIATRICS	2012	170
Impact of hemochromatosis gene mutations on cardiac status in doxorubicin‐treated survivors of childhood high‐risk leukemia Steven E. Lipshultz, Stuart R. Lipsitz, Jeffery L. Kutok, Cancer	2013	158
<i>Erwinia</i> asparaginase after allergy to <i>E. coli</i> asparaginase in children with acute lymphoblastic leukemia Lynda M. Vrooman, Jeffrey G. Supko, Donna Neuberg, Pediatric Blood & Cancer	2009	158
Thrombosis in children with acute lymphoblastic leukemia Uma H. Athale, Anthony K.C. Chan Thrombosis Research	2003	131
Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer Uma H. Athale, Sabrina Siciliano, Lehana Thabane, Pediatric Blood & Cancer	2008	126

Page 1